The pulmonary drug delivery systems market is expected to be around US$ 56.50 Billion by 2028 at a CAGR of 4.5% in the given forecast period.
Growth in the predominance of chronic diseases, for example, bronchitis, tuberculosis, and chronic obstructive pulmonary disease, constraints of customary medicines for pneumonic conveyance, the better vulnerability of medication, least dose prerequisite, technological progressions, and growth in smoking is expected to drive the market.
Pulmonary drug delivery systems convey medication to the lung for the treatment of illnesses of the respiratory tract.
The global Pulmonary Drug Delivery Systems market is segregated on the basis of Application as COPD, Allergic Rhinitis, Asthma, Cystic Fibrosis, and Others. Based on Product the global Pulmonary Drug Delivery Systems market is segmented in Dry Powder Inhalers, Metered Dose Inhalers, and Nebulizers. Based on Distribution Channel the global Pulmonary Drug Delivery Systems market is segmented in E-Commerce, Retail Pharmacies, and Hospital Pharmacies.
Based on End-Users, the global Pulmonary Drug Delivery Systems market is segmented in Clinics, Hospitals, and Homecare.
The global Pulmonary Drug Delivery Systems market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Pulmonary Drug Delivery Systems market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
NOVARTIS AG, KONINKLIJKE PHILIPS N.V., 3M COMPANY, ASTRAZENECA PLC., CLEMENT CLARKE INTERNATIONAL., AEROGEN, ACTELION PHARMACEUTICALS LTD, BRIGGS HEALTHCARE, BOEHRINGER INGELHEIM GMBH, GLAXOSMITHKLINE PLC, and others are among the major players in the global Pulmonary Drug Delivery Systems market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Pulmonary Drug Delivery Systems Market has been segmented as below:
Pulmonary Drug Delivery Systems Market, By Application
Pulmonary Drug Delivery Systems Market, By Product
Pulmonary Drug Delivery Systems Market, By Distribution Channel
Pulmonary Drug Delivery Systems Market, By End-Users
Pulmonary Drug Delivery Systems Market, By Region
Pulmonary Drug Delivery Systems Market, By Company
The report covers:
Report Scope:
The global Pulmonary Drug Delivery Systems market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Pulmonary Drug Delivery Systems market share. Major industry players with significant revenue share include NOVARTIS AG, KONINKLIJKE PHILIPS N.V., 3M COMPANY, ASTRAZENECA PLC., CLEMENT CLARKE INTERNATIONAL., AEROGEN, ACTELION PHARMACEUTICALS LTD, BRIGGS HEALTHCARE, BOEHRINGER INGELHEIM GMBH, GLAXOSMITHKLINE PLC, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our New Reports :-
Veterinary/Animal Vaccines Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Pulmonary Drug Delivery Systems Market, By Application
5.1 Introduction
5.2 COPD
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Allergic Rhinitis
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Asthma
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Cystic Fibrosis
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 Others
5.6.1 Market Overview
5.6.2 Market Size and Forecast
6. Pulmonary Drug Delivery Systems Market, By Product
6.1 Introduction
6.2 Dry Powder Inhalers
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Metered Dose Inhalers
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Nebulizers
6.4.1 Market Overview
6.4.2 Market Size and Forecast
7. Pulmonary Drug Delivery Systems Market, By Distribution Channel
7.1 Introduction
7.2 E-Commerce
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Retail Pharmacies
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Hospital Pharmacies
7.4.1 Market Overview
7.4.2 Market Size and Forecast
8. Pulmonary Drug Delivery Systems Market, By End-Users
8.1 Introduction
8.2 Clinics
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 Hospitals
8.3.1 Market Overview
8.3.2 Market Size and Forecast
8.4 Homecare
8.4.1 Market Overview
8.4.2 Market Size and Forecast
9. Pulmonary Drug Delivery Systems Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 North America Pulmonary Drug Delivery Systems, By Application
9.2.2 North America Pulmonary Drug Delivery Systems, By Product
9.2.3 North America Pulmonary Drug Delivery Systems, By Distribution Channel
9.2.4 North America Pulmonary Drug Delivery Systems, By End-Users
9.3 Europe
9.3.1 Europe Pulmonary Drug Delivery Systems, By Application
9.3.2 Europe Pulmonary Drug Delivery Systems, By Product
9.3.3 Europe Pulmonary Drug Delivery Systems, By Distribution Channel
9.3.4 Europe Pulmonary Drug Delivery Systems, By End-Users
9.4 Asia-Pacific
9.4.1 Asia-Pacific Pulmonary Drug Delivery Systems, By Application
9.4.2 Asia-Pacific Pulmonary Drug Delivery Systems, By Product
9.4.3 Asia-Pacific Pulmonary Drug Delivery Systems, By Distribution Channel
9.4.4 Asia-Pacific Pulmonary Drug Delivery Systems, By End-Users
9.5 Rest of the World
9.5.1 Rest of the World Pulmonary Drug Delivery Systems, By Application
9.5.2 Rest of the World Pulmonary Drug Delivery Systems, By Product
9.5.3 Rest of the World Pulmonary Drug Delivery Systems, By Distribution Channel
9.5.4 Rest of the World Pulmonary Drug Delivery Systems, By End-Users
10. Competitive Insights
10.1 Key Insights
10.2 Company Market Share Analysis
10.3 Strategic Outlook
10.3.1 Mergers & Acquisitions
10.3.2 New Product Development
10.3.3 Portfolio/Production Capacity Expansions
10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5 Others
11. Company Profiles
11.1 NOVARTIS AG
11.1.1 Company Overview
11.1.2 Product/Service Landscape
11.1.3 Financial Overview
11.1.4 Recent Developments
11.2 KONINKLIJKE PHILIPS N.V.
11.2.1 Company Overview
11.2.2 Product/Service Landscape
11.2.3 Financial Overview
11.2.4 Recent Developments
11.3 3M COMPANY
11.3.1 Company Overview
11.3.2 Product/Service Landscape
11.3.3 Financial Overview
11.3.4 Recent Developments
11.4 ASTRAZENECA PLC.
11.4.1 Company Overview
11.4.2 Product/Service Landscape
11.4.3 Financial Overview
11.4.4 Recent Developments
11.5 CLEMENT CLARKE INTERNATIONAL.
11.5.1 Company Overview
11.5.2 Product/Service Landscape
11.5.3 Financial Overview
11.5.4 Recent Developments
11.6 AEROGEN
11.6.1 Company Overview
11.6.2 Product/Service Landscape
11.6.3 Financial Overview
11.6.4 Recent Developments
11.7 ACTELION PHARMACEUTICALS LTD
11.7.1 Company Overview
11.7.2 Product/Service Landscape
11.7.3 Financial Overview
11.7.4 Recent Developments
11.8 BRIGGS HEALTHCARE
11.8.1 Company Overview
11.8.2 Product/Service Landscape
11.8.3 Financial Overview
11.8.4 Recent Developments
11.9 BOEHRINGER INGELHEIM GMBH
11.9.1 Company Overview
11.9.2 Product/Service Landscape
11.9.3 Financial Overview
11.9.4 Recent Developments
11.10 GLAXOSMITHKLINE PLC
11.10.1 Company Overview
11.10.2 Product/Service Landscape
11.10.3 Financial Overview
11.10.4 Recent Developments
The Pulmonary Drug Delivery Systems Market has been segmented as below:
Pulmonary Drug Delivery Systems Market, By Application
Pulmonary Drug Delivery Systems Market, By Product
Pulmonary Drug Delivery Systems Market, By Distribution Channel
Pulmonary Drug Delivery Systems Market, By End-Users
Pulmonary Drug Delivery Systems Market, By Region
Pulmonary Drug Delivery Systems Market, By Company
